Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients

Abstract Azvudine (FNC) is a nucleoside analog that inhibits HIV-1 RNA-dependent RNA polymerase (RdRp). Recently, we discovered FNC an agent against SARS-CoV-2, and have taken it into Phase III trial for COVID-19 patients. FNC monophosphate analog inhibited SARS-CoV-2 and HCoV-OC43 coronavirus with...

Full description

Bibliographic Details
Main Authors: Jin-Lan Zhang, Yu-Huan Li, Lu-Lu Wang, Hong-Qi Liu, Shuai-Yao Lu, Yong Liu, Ke Li, Bin Liu, Su-Yun Li, Feng-Min Shao, Kun Wang, Ning Sheng, Rui Li, Jin-Jin Cui, Pei-Chun Sun, Chun-Xia Ma, Bo Zhu, Zhe Wang, Yuan-Hao Wan, Shi-Shan Yu, Yongsheng Che, Chao-Yang Wang, Chen Wang, Qiangqian Zhang, Li-Min Zhao, Xiao-Zhong Peng, Zhenshun Cheng, Jun-Biao Chang, Jian-Dong Jiang
Format: Article
Language:English
Published: Nature Publishing Group 2021-12-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00835-6

Internet

https://doi.org/10.1038/s41392-021-00835-6

Similar Items